Crypto Titans Invest in Biotech Revolution
Crypto billionaires are channeling their wealth into a new scientific frontier: biotech. Major crypto figures are spearheading a novel funding model for biotech and science.
On June 1, Binance’s founder, Changpeng Zhao, announced a $10 million BNB donation to Ethereum’s Vitalik Buterin. Buterin’s open-source biotech projects.
This donation complements YZi Labs’ investments in similar biotech initiatives. Zhao, with a $65 billion net worth, sees this as his contribution to advancing biotech.
Buterin envisions decentralized biotech as a solution to corporate dominance in science. He believes blockchain principles like transparency and open-source development can democratize scientific progress. In a 2023 blog post,Buterin outlined how blockchain can transform biotech.
Currently, biotech is dominated by profit-driven corporations. Buterin proposes using blockchain’s transparency and privacy features to create a decentralized biotech ecosystem. This could lead to open-source vaccine protocols and pocket air testers, saving lives during pandemics.
Buterin’s vision includes using crypto for funding public goods. He has donated millions from memecoins to his biotech fund. Zhao’s donation, alongside YZi Labs’ investments, aims to support mission-driven talent and advance the field.
Buterin believes decentralized science can benefit everyone. For example, zero-knowledge proofs can protect public health while preserving privacy. Self-reliant researchers can develop tools quickly, ensuring scientific progress works for all.
buterin’s decentralized science concept could revolutionize biotech. By applying blockchain principles, we can foster a community-driven approach to scientific innovation.
For more details, check Buterin’s blog post.
